These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5453131)

  • 1. [Hormonal treatment of renal cancers with anhydrohydroxyprogesterone (Ethisterone)].
    Mazurek L; Jeromin L; Stapor K; Brauner G; Wiernicki J
    Pol Przegl Chir; 1970; 42(6):Suppl 6a:962+. PubMed ID: 5453131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined treatment of premenstrual tension syndrome with dehydrating and hormonal agents].
    Potocki J; Guzel L; Szymborski A
    Wiad Lek; 1969 Nov; 22(22):2047-50. PubMed ID: 5392145
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal treatment of Grawitz tumour of the kidney. (A contribution).
    Jakoubková J; Bek V; Havránková N; Abrahámová J; Kvapil F
    Neoplasma; 1970; 17(3):321-7. PubMed ID: 5430502
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine aspects of renal carcinoma.
    Murnaghan GF
    Br J Urol; 1972 Feb; 44(1):126. PubMed ID: 5036013
    [No Abstract]   [Full Text] [Related]  

  • 5. A preliminary report of mitotane therapy of advanced renal and prostate cancer.
    Hogan TF; Citrin DL; Freeberg BL
    Cancer Treat Rep; 1981; 65(5-6):539-40. PubMed ID: 7237479
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of tamoxifen in patients with advanced renal cell carcinoma.
    Glick JH; Wein A; Torri S; Alavi J; Harris D; Brodovsky H
    Cancer Treat Rep; 1980; 64(2-3):343-4. PubMed ID: 7407768
    [No Abstract]   [Full Text] [Related]  

  • 8. Treosulfan in the treatment of metastatic renal cell carcinoma.
    Rigos D; Wechsel HW; Bichler KH
    Anticancer Res; 1999; 19(2C):1549-52. PubMed ID: 10365143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of poorly responding tumors in the metastatic stage].
    Gremmel H; Liffers R
    Med Welt; 1980 Oct; 31(43):1554-6. PubMed ID: 7464515
    [No Abstract]   [Full Text] [Related]  

  • 10. [On some indications of estroprogestative treatment in gynecology].
    Perego A
    Ann Ostet Ginecol; 1965 Jul; 87(7):487-96. PubMed ID: 5845229
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
    Fosså SD; Wik B; Bae E; Lien HH
    Cancer Treat Rep; 1982 May; 66(5):1219-21. PubMed ID: 6952962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debulking nephrectomy followed by a "watch and wait" approach in metastatic renal cell carcinoma.
    Wong AS; Chong KT; Heng CT; Consigliere DT; Esuvaranathan K; Toh KL; Chuah B; Lim R; Tan J
    Urol Oncol; 2009; 27(2):149-54. PubMed ID: 18439851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma.
    Bell DR; Aroney RS; Fisher RJ; Levi JA
    Cancer Treat Rep; 1984 Apr; 68(4):587-90. PubMed ID: 6201268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of endovascular treatment of metastatic renal cell cancer].
    Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
    Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
    Schneider RJ; Woodcock TM; Yagoda A
    Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
    [No Abstract]   [Full Text] [Related]  

  • 16. [Luteal substitution with the use of ethisterone in women with anovulatory cycles].
    Radwańska E; Jedrzejewski M; Ladygin E; Witkowski L
    Ginekol Pol; 1968 Oct; 39(10):1167-77. PubMed ID: 5707758
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal cell carcinomata with slow growth and prolonged survival.
    Haddad FS
    J Med Liban; 1999; 47(3):201-4. PubMed ID: 10550948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.
    Haas NB; Smith M; Lewis N; Littman L; Yeslow G; Joshi ID; Murgo A; Bradley J; Gordon R; Wang H; Rogatko A; Hudes GR
    Clin Cancer Res; 2003 Jan; 9(1):109-14. PubMed ID: 12538458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma.
    Redman BG; Hillman GG; Flaherty L; Forman J; Dezso B; Haas GP
    Clin Cancer Res; 1998 Feb; 4(2):283-6. PubMed ID: 9516912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.